Maximum intravenous alteplase dose for obese stroke patients is not associated with greater likelihood of worse outcomes Article

Ravipati, Kaushik, Guillen, Roboan, Belnap, Starlie et al. (2021). Maximum intravenous alteplase dose for obese stroke patients is not associated with greater likelihood of worse outcomes . Thrombosis Research, 204 76-80. 10.1016/j.thromres.2021.06.002

cited authors

  • Ravipati, Kaushik; Guillen, Roboan; Belnap, Starlie; Saxena, Anshul; Veledar, Emir; Starosciak, Amy K; La Rosa, Felipe De Los Rios

sustainable development goals

authors

publication date

  • August 1, 2021

published in

keywords

  • Cardiovascular System & Cardiology
  • Hematology
  • IV alteplase
  • Ischemic stroke
  • Life Sciences & Biomedicine
  • Obesity
  • Outcome
  • Peripheral Vascular Disease
  • Science & Technology
  • URGENT THERAPY

Digital Object Identifier (DOI)

start page

  • 76

end page

  • 80

volume

  • 204